Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$58.87 - $83.05 $1.96 Million - $2.76 Million
33,282 Added 79.34%
75,232 $6.04 Million
Q1 2024

May 14, 2024

BUY
$51.07 - $68.26 $513,815 - $686,763
10,061 Added 31.55%
41,950 $2.61 Million
Q4 2023

Feb 09, 2024

BUY
$55.6 - $77.89 $1.77 Million - $2.48 Million
31,889 New
31,889 $1.98 Million
Q2 2023

Aug 11, 2023

BUY
$82.41 - $99.65 $3.18 Million - $3.85 Million
38,608 Added 180.98%
59,941 $5.03 Million
Q1 2023

May 15, 2023

SELL
$47.76 - $82.86 $6.72 Million - $11.7 Million
-140,722 Reduced 86.84%
21,333 $1.76 Million
Q4 2022

Feb 13, 2023

BUY
$48.76 - $77.67 $5.17 Million - $8.23 Million
105,948 Added 188.83%
162,055 $8.26 Million
Q3 2022

Nov 14, 2022

BUY
$61.42 - $86.29 $592,703 - $832,698
9,650 Added 20.77%
56,107 $3.95 Million
Q2 2022

Aug 11, 2022

SELL
$55.54 - $72.65 $3.91 Million - $5.12 Million
-70,489 Reduced 60.27%
46,457 $3.07 Million
Q1 2022

May 13, 2022

BUY
$24.28 - $56.64 $2.84 Million - $6.62 Million
116,946 New
116,946 $6.47 Million
Q1 2021

May 13, 2021

SELL
$13.77 - $21.66 $143,979 - $226,476
-10,456 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$10.75 - $14.91 $112,402 - $155,898
10,456 New
10,456 $141,000
Q3 2019

Nov 08, 2019

SELL
$21.01 - $28.94 $183,018 - $252,096
-8,711 Closed
0 $0
Q2 2019

Aug 09, 2019

SELL
$23.33 - $28.3 $42,763 - $51,873
-1,833 Reduced 17.38%
8,711 $247,000
Q1 2019

May 13, 2019

BUY
$14.93 - $25.1 $157,421 - $264,654
10,544 New
10,544 $258,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.1B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.